Pharma and BioTech Daily

Pharma and Biotech Daily: Navigating the Complexities of mRNA Technology and Gene Therapies


Listen Later

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A patient death has led to the halt of Rocket's gene therapy trial for Danon disease, due to complications from an acute systemic infection. This incident highlights the unpredictable nature of gene therapies and may pose challenges for investment in the field. On the other hand, mRNA technology has been both helped and hindered by the COVID-19 pandemic. While the pandemic has increased interest and funding in mRNA research, vocal skeptics of COVID-19 vaccinations have negatively impacted the reputation of mRNA technology. Despite this, some see promise in mRNA for therapeutics in cancer and rare diseases.In other news, Prothena is considering business options after a failed phase III trial, and a new biotech company has been launched to focus on neuro diseases. Additionally, AGC Biologics will be at Bio International to showcase their capabilities in protein biologics and advanced therapies.mRNA technology played a significant role in combating COVID-19, but is now facing scrutiny due to vaccine skeptics and cuts in government funding for research. Despite this, the pandemic accelerated advancements in mRNA therapeutics for cancer and rare diseases. The lack of FDA-approved treatments for rare diseases, particularly in children, highlights a critical need for innovation in this area. The American Association for Cancer Research's annual conference will unveil data that could impact cancer treatment, while the future of vaccine development faces challenges amidst regulatory changes and funding issues. Additionally, advancements in cell and gene therapy are on the horizon. Suggestions for coverage topics in the biopharma industry are welcomed.
...more
View all episodesView all episodes
Download on the App Store

Pharma and BioTech DailyBy Pharma and BioTech News

  • 3.6
  • 3.6
  • 3.6
  • 3.6
  • 3.6

3.6

11 ratings


More shows like Pharma and BioTech Daily

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,643 Listeners

NPR News Now by NPR

NPR News Now

14,191 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,716 Listeners

Planet Money by NPR

Planet Money

30,718 Listeners

Bloomberg Businessweek by Bloomberg

Bloomberg Businessweek

443 Listeners

WSJ Minute Briefing by The Wall Street Journal

WSJ Minute Briefing

661 Listeners

Equity by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, Theresa Loconsolo

Equity

339 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

121 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,508 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,955 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

18 Listeners

The Wall Street Skinny by Kristen and Jen

The Wall Street Skinny

194 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

127 Listeners